Stress and neuroinflammation

Modern Trends in Pharmacopsychiatry

Volumn 28, Issue , 2013, Pages 20-32

  Grippo, Angela J ^a   Scotti, Melissa Ann L ^a,b  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CATECHOLAMINE; CYCLOOXYGENASE 2; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; ISOPRENALINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NITRIC OXIDE; PRAZOSIN; PROPRANOLOL; STRESS HORMONE; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DISEASE COURSE; IMMUNE RESPONSE; MENTAL STRESS; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; NERVOUS SYSTEM DISEASES; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; CATECHOLAMINES; CYCLOOXYGENASE 2; CYTOKINES; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES; NEUROPEPTIDE Y; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; STRESS, PSYCHOLOGICAL; SUBSTANCE P;

EID: 84880789312     PISSN: 16622685     EISSN: 16624505     Source Type: Book Series    
DOI: 10.1159/000343965     Document Type: Article

References (99)

1. Glaser R, Kiecolt-Glaser JK: Stressinduced immune dysfunction: Implications for health. Nat Rev Immunol 2005;5:243-251
2. Johnson AK, Anderson EA: Stress and arousal; in Cacioppo JT, Tassinary LG, (eds): Principles of Psychophysiology: Physical, Social, and Inferential Elements. New York, Cambridge University Press, 1990
3. Maier SF, Watkins LR: Cytokines for psychologists: Implications of bidirectional immune-To-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107
4. McGrath JE: Settings, measures, and themes: An integrative review of some research on social-psychological factors in stress; in McGrath JE (ed): Social and Psychological Factors in Stress. New York, Holt, Rinehart &Winston, 1970, pp 76-83
5. Sapolsky RM, Romero LM, Munck AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89
6. Dhabhar FS, McEwen BS: Stress-induced enhancement of antigen-specific cellmediated immunity. J Immunol 1996; 156:2608-2615
7. Dhabhar FS, McEwen BS: Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: A potential role for leukocyte trafficking. Brain Behav Immun 1997; 11:286-306
8. Cannon WB: Bodily Changes in Pain, Hunger, Fear and Rage. Oxford, Appleton, 1929
9. Selye H: A syndrome produced by diverse nocuous agents. Nature 1936; 138:32-33
10. Mason JW: A review of psychoendocrine research on the pituitary-Adrenal cortical system. Psychosom Med 1968;30: 576-607
11. Lazarus RS: From psychological stress to the emotions: A history of changing outlooks. Annu Rev Psychol 1993;44:1-21
12. Selye H: In Vivo: The Case for Supramolecular Biology. New York, Liveright, 1967
13. Chrousos GP: The stress response and immune function: Clinical implications: The 1999 Novera H. Spector Lecture. Ann NY Acad Sci 2000;917:38-67
14. Gold P, Chrousos G: Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs. low CRH/NE states. Mol Psychiatry 2002;7:254-275
15. De Souza EB, Grigoriadis DE: Physiology, pharmacology, and role in central nervous system and immune disorders; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 505-517
16. Sirinathsinghji DJS, Rees LH, Rivier J, Vale W: Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983;305: 232-235
17. Glowa J, Gold P: Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey. Neuropeptides 1991;18:55-61
18. Krahn DD, Gosnell BA, Levine AS, Morley JE: Behavioral effects of corticotropin-releasing factor: Localization and characterization of central effects. Brain Res 1988;443:63-69
19. Kirby LG, Rice KC, Valentino RJ: Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000;22:148-162
20. Lehnert H, Schulz C, Dieterich K: Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: The role of the locus coeruleus. Neurochem Res 1998;23:1039-1052
21. Brown M, Fisher L, Spiess J, River C, River J, Vale W: Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology 1982;111:928-931
22. Fisher LA: Corticotropin-releasing factor: Endocrine and autonomic integration of responses to stress. Trends Pharmacol Sci 1989;10:189-193
23. Aston-Jones G, Rajkowski J, Kubiak P, Valentino RJ, Shipley MT: Role of the locus coeruleus in emotional activation. Prog Brain Res 1996;107:379-402
24. Black PH: Stress and the inflammatory response: A review of neurogenic inflammation. Brain Behav Immun 2002;16:622-653
25. Garcia-Bueno B, Caso JR, Leza JC: Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms. Neurosci Biobehav Rev 2008;32:1136-1151
26. Collins SM: Stress and the gastrointestinal tract. IV. Modulation of intestinal inflammation by stress: Basic mechanisms and clinical relevance. Am J Physiol 2001;280:G315-G318
27. Black PH, Garbutt LD: Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1-23
28. Daemen M, Kurvers H, Kitslaar PJ, Slaaf DW, Bullens P, Van Den Wildenberg F: Neurogenic inflammation in an animal model of neuropathic pain. Neurol Res 1998;20:41
29. Payan DG: Neuropeptides and inflammation: The role of substance P. Annu Rev Med. 1989;40:341-352
30. Rosenkranz MA: Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol Bull 2007;133:1007-1037
31. Basbaum AI, Levine JD: The contribution of the nervous system to inflammation and inflammatory disease. Can J Physiol Pharmacol 1991;69:647-651
32. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E: Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998;281: 1640-1645
33. Saria A: Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br J Pharmacol 1984;82: 217-222
34. Colpaert F, Donnerer J, Lembeck F: Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci. 1983;32:1827-1834
35. Levine J, Dardick S, Basbaum A, Scipio E: Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci 1985;5:1380-1386
36. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC: Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun 1999;13: 225-239
37. Zukowska-Grojec Z, Konarska M, McCarty R: Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci 1988;42: 1615-1624
38. Prod'homme T, Weber MS, Steinman L, Zamvil SS: A neuropeptide in immunemediated inflammation, Y Trends Immunol 2006;27:164-167
39. Li L, Lee EW, Ji H, Zukowska Z: Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol 2003;23:1204-1210
40. Morgan CA, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G: Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: Replication and extension of previous report. Biol Psychiatry 2002;52:136-142
41. Heilig M, Soderpalm B, Engel JA, Widerlov E: Centrally administered neuropeptide Y (NPY) produces anxiolyticlike effects in animal anxiety models. Psychopharmacology 1989;98:524-529
42. Zukowska Z, Pons J, Lee EW, Li L: Neuropeptide Y: A new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 2003;81:89-94
43. Li L, Jonsson-Rylander AC, Abe K, Zukowska Z: Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arterioscler Thromb Vasc Biol 2005;25: 2075-2080
44. Hadley ME: Endocrinology, ed 5. Upper Saddle River, Prentice-Hall, 2000
45. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19:269-301
46. Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM: The stressed CNS: When glucocorticoids aggravate inflammation. Neuron 2009;64:33-39
47. Sorrells SF, Sapolsky RM: An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007;21: 259-272
48. Patel PD, Katz M, Karssen AM, Lyons DM: Stress-induced changes in corticosteroid receptor expression in primate hippocampus and prefrontal cortex. Psychoneuroendocrinology 2008;33:360-367
49. Sapolsky RM: Endocrinology of the stress response; in Becker JB, Breedlove SB, Crews D, McCarthy MM, (eds): Behavioral Endocrinology. Cambridge, MIT Press, 2002, pp 409-450
50. Dhabhar FS, McEwen BS: Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 1999;96:1059-1064
51. Dhabhar FS, Miller AH, McEwen BS, Spencer RL: Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 1996;157:1638-1644
52. Munhoz C, Garcia-Bueno B, Madrigal J, Lepsch L, Scavone C, Leza J: Stressinduced neuroinflammation: Mechanisms and new pharmacological targets. Braz J Med Biol Res 2008;41:1037-1046
53. Madrigal JLM, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, Leza JC: Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor ?β-mediated mechanisms. J Neurochem 2001;76:532-538
54. Madrigal J, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, Bosca L, Leza JC: Induction of cyclooxygenase-2 accounts for restraint stressinduced oxidative status in rat brain. Neuropsychopharmacology 2003;28: 1579-1588
55. Madrigal JLM, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, Leza JC: The increase in TNF-[alpha] levels is implicated in NF-[kappa] B activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002;26:155-163
56. Garcia-Bueno B, Madrigal JLM, Perez-Nievas BG, Leza JC: Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-Activated receptor-? activation after stress in rats. Endocrinology 2008;149:1969-1978
57. De Pablos R, Villaran R, Arguelles S, Herrera A, Venero J, Ayala A, Cano J, Machado A: Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 2006;26:5709-5719
58. Johnson J, Campisi J, Sharkey C, Kennedy S, Nickerson M, Greenwood B, Fleshner M: Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005;135:1295-1307
59. Dantzer R: Cytokine, sickness behavior, and depression. Neurol Clin 2006;24: 441-460
60. Commins SP, Borish L, Steinke JW: Immunologic messenger molecules: Cytokines, interferons and chemokines. J Allergy Clin Immunol 2010; 125:S53-S72
61. Licinio J, Wong ML: Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 1997;100:2941-2947
62. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56
63. Kim YK, Maes M: The role of the cytokine network in psychological stress. Acta Neuropsychiatr 2003;15:148-155
64. Kop WJ, Gottdiener JS: The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 2005;67:S37-S41
65. Boutin H, LeFeuvre R, Horai R, Asano M, Iwakura Y, Rothwell N: Role of IL-1a and IL-1β in ischemic brain damage. J Neurosci 2001;21:5528-5534
66. Allan SM, Rothwell NJ: Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744
67. Arvin B, Neville LF, Barone FC, Feuerstein GZ: The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996;20:445-452
68. Lucas SM, Rothwell NJ, Gibson RM: The role of inflammation in CNS injury and disease. Br J Pharmacol 2006;147: S232-S240
69. Hillhouse E, Kida S, Iannotti F: Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1[beta] in the cerebral cortex. Neurosci Lett 1998;249: 177-179
70. Toulmond S, Rothwell N: Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995;671: 261-266
71. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K: Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995;26:676-681
72. Lawrence CB, Allan SM, Rothwell NJ: Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 1998;10:1188-1195
73. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF: Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci 1998;18:2239-2246
74. Ackerman KD, Martino M, Heyman R, Moyna NM, Rabin BS: Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med 1998;60:484-491
75. McCarthy DO, Ouimet ME, Daun JM: The effects of noise stress on leukocyte function in rats. Res Nurs Health 1992; 15:131-137
76. Koo JW, Duman RS: IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 2008;105:751-756
77. Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45: 491-503
78. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74-80
79. Kinouchi K, Brown G, Pasternak G, Donner DB: Identification and characterization of receptors for tumor necrosis factor-[alpha] in the brain. Biochem Biophys Res Commun 1991;181:1532-1538
80. Hallenbeck JM: The many faces of tumor necrosis factor in stroke. Nat Med 2002;8:1363-1368
81. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP: Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Flow Metab 1998;18:1283-1287
82. Slavich GM, Way BM, Eisenberger NI, Taylor SE: Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc Natl Acad Sci USA 2010;107:14817-14822
83. O'Connor KA, Johnson JD, Hansen MK, Wieseler Frank JL, Maksimova E, Watkins LR, Maier SF: Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res 2003;991:123-132
84. Penkowa M, Giralt M, Carrasco J, Hadberg H, Hidalgo J: Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-Deficient mice. Glia 2000;32:271-285
85. Maes M, Lin A, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999;45:833-839
86. Black PH: The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006;67:879-891
87. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, Ferstl R, Von Eynatten M, Wendt T, Rudofsky G: A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003;100:1920-1925
88. Padgett DA, Glaser R: How stress influences the immune response. Trends Immunol 2003;24:444-448
89. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, de Sa Lima L, Avellar MCW, Sapolsky RM, Scavone C: Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-B in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 2006;26:3813-3820
90. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2001;2:907-916
91. Gross SS, Wolin M: Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol 1995;57:737-769
92. Moncada S, Palmer R, Higgs E: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142
93. Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424
94. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, Bosca L, Leza JC: Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 2000;74:785-791
95. Madrigal JLM, Moro MA, Lizasoain I, Lorenzo P, Leza JC: Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res 2002;938:87-91
96. Pasinetti GM: Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions. J Neurosci Res 1998;54: 1-6
97. Nogawa S, Zhang F, Ross ME, Iadecola C: Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17:2746-2755
98. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T: Prostaglandin E2 induces caspase-Dependent apoptosis in rat cortical cells. Neurosci Lett 2002;317:61-64
99. Phillis JW, Horrocks LA, Farooqui AA: Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res Rev 2006;52:201-243